GGrantIndex
← Leaderboards

Brian M D'onofrio

University Of Virginia Charlottesville

$2,961,723
Attributed
$5,094,249
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $779.8K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,094,249 · 5

By mechanism

R01$5,044,883 · 4
F31$49,366 · 1

Top collaborators

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelDesignPharmaceutical PreparationsSamplingInnovationAdverse OutcomeData SetBaseCohortObservational StudyAttention Deficit Hyperactivity DisorderMedicalPopulation BasedSwedenInternationalExperimental DesignsAdverse EffectsIndexingBipolar DisorderEpidemiologyBasic ScienceAlcohol Or Other Drugs UseChildBenefits And Risks

Grant awards (15)

Examining the Effects of ADHD Medications on Substance-Related Morbidity and Mortality Among Young People$779,831
R01 · FY2025 · DA · contact PI
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes$397,357
R01 · FY2021 · DA · contact PI
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes$9,193
R01 · FY2021 · DA · contact PI
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes$397,357
R01 · FY2020 · DA · contact PI
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes$423,021
R01 · FY2019 · DA · contact PI
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$408,990
R01 · FY2017 · MH · contact PI
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$442,603
R01 · FY2016 · MH · contact PI
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$408,990
R01 · FY2015 · MH · contact PI
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$438,320
R01 · FY2014 · MH · contact PI
Quasi-experimental studies of early risk factors for severe psychopathology$324,390
R01 · FY2013 · HD · contact PI
Quasi-experimental studies of early risk factors for severe psychopathology$332,956
R01 · FY2012 · HD · contact PI
Quasi-experimental studies of early risk factors for severe psychopathology$327,706
R01 · FY2011 · HD · contact PI
Quasi-experimental studies of early risk factors for severe psychopathology$354,169
R01 · FY2010 · HD · contact PI
Determinants of Behavior Problems after Divorce$25,481
F31 · FY2003 · MH
Determinants of Behavior Problems after Divorce$23,885
F31 · FY2002 · MH